V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210027927 | 210013499 | null | null | Palliative (P) | 2013-04-28 | 2013-05-14 | CNS Low Grade Glioma Vinblastine | N | N | 210041073 | VINBLASTINE |
| 210027928 | 210013501 | 1.78 | 36 | Palliative (P) | 2014-02-26 | 2014-02-26 | PONATINIB | N | N | 210041084 | CARBOPLATIN + ETOPOSIDE |
| 210027929 | 210013503 | 1.78 | 84.6 | Disease modification (D) | 2015-06-10 | 2015-06-10 | Methotrexate High Dose (3g/m2) | N | N | 210041092 | CHOP |
| 210027930 | 210013505 | 1.6 | 103.6 | Palliative (P) | 2016-01-02 | 2016-02-07 | Cladribine (subcut) 5 days | Y | N | 210041101 | CLADRIBINE |
| 210027931 | 210022457 | 1.72 | 78.4 | Curative (C) | 2016-06-03 | 2016-07-31 | CYCLOPHOSPHAMIDE | N | N | 210041103 | CYCLOPHOSPHAMIDE |
| 210027932 | 210022457 | 1.75 | 94.4 | Disease modification (D) | 2017-01-07 | 2017-03-25 | Inotuzumab Ozogamicin | N | N | 210041103 | INOTUZUMAB OZOGAMICIN |
| 210027933 | 210013508 | 1.35 | 55 | Curative (C) | null | 2017-06-14 | Bevacizumab 10mg/kg | Y | N | 210041106 | RIALTO TRIAL |
| 210027934 | 210013510 | 1.9 | null | Disease modification (D) | 2016-04-15 | 2016-04-21 | Inotuzumab Ozogamicin | N | N | 210041115 | PONATINIB |
| 210027935 | 210013512 | null | 30 | Curative (C) | 2015-01-17 | 2015-01-27 | Vinblastine | 2 | N | 210041122 | VINBLASTINE |
| 210027936 | 210022462 | 1.86 | null | Palliative (P) | 2018-04-29 | 2018-06-17 | Cyclophosphamide + Vincristine | N | N | 210041127 | PONATINIB |
| 210027937 | 210013516 | 1.6 | 85.4 | Curative (C) | null | 2015-05-22 | Methotrexate High Dose (3g/m2) | null | Y | 210041160 | METHOTREXATE HIGH DOSE |
| 210027938 | 210013517 | 1.83 | 69 | Curative (C) | null | 2013-06-19 | CNS Low Grade Glioma Vinblastine | null | N | 210041181 | VINBLASTINE |
| 210027939 | 210013518 | 1.86 | 66 | null | 2017-08-26 | 2017-08-26 | Bevacizumab 10mg/kg | 02 | N | 210041191 | PONATINIB |
| 210027940 | 210013520 | null | null | Palliative (P) | 2017-11-24 | 2017-11-26 | CYCLOPHOSPHAMIDE | 2 | N | 210041193 | CYCLOPHOSPHAMIDE |
| 210027941 | 210013525 | 0 | 83.5 | Curative (C) | null | 2018-05-30 | LOMUSTINE + PROCARBAZINE | null | null | 210041199 | LOMUSTINE + PROCARBAZINE |
| 210027942 | 210013529 | 1.64 | 61.6 | Disease modification (D) | null | 2017-12-03 | CYCLOPHOSPHAMIDE | N | N | 210041223 | CYCLOPHOSPHAMIDE |
| 210027943 | 210028089 | null | 67.1 | Palliative (P) | 2017-06-15 | 2017-08-29 | UKALL XII Consolidation 2 & 4 | N | N | 210041236 | RIALTO TRIAL |
| 210027944 | 210013530 | 1.68 | 32.9 | Disease modification (D) | 2013-08-28 | 2013-08-28 | Methotrexate High Dose (3g/m2) | N | N | 210041244 | METHOTREXATE HIGH DOSE |
| 210027946 | 210022470 | 1.67 | 11.4 | Palliative (P) | 2016-10-09 | 2016-11-05 | PONATINIB | N | N | 210041263 | BENDAMUSTINE |
| 210027947 | 210013536 | 1.64 | 60 | Adjuvant (A) | 2018-06-07 | 2018-06-09 | UKALL XII Consolidation 2 & 4 | 02 | N | 210041266 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210027948 | 210013538 | 1.77 | null | Curative (C) | 2016-03-13 | 2016-03-13 | CHLORAMBUCIL + OFATUMUMAB | 2 | N | 210041279 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210027949 | 210013540 | null | 26 | Curative (C) | 2017-11-25 | 2017-12-17 | CLADRIBINE | 02 | N | 210041303 | CLADRIBINE |
| 210027950 | 210013542 | 0 | 79.2 | null | 2018-02-16 | 2018-03-09 | LOMUSTINE + PROCARBAZINE | N | N | 210041335 | LOMUSTINE + PROCARBAZINE |
| 210027951 | 210013545 | 1.67 | null | null | 2015-09-09 | 2015-09-17 | Cladribine (subcut) 5 days | N | N | 210041346 | CLADRIBINE |
| 210027952 | 210013547 | 1.62 | 61.6 | Disease modification (D) | null | 2017-09-14 | Cladribine (subcut) 5 days | Y | N | 210041346 | CLADRIBINE |
| 210027953 | 210022475 | 1.7 | 74.6 | Palliative (P) | 2015-09-16 | 2016-02-03 | LOMUSTINE + PROCARBAZINE | null | null | 210041357 | LOMUSTINE + PROCARBAZINE |
| 210027954 | 210022477 | null | null | Curative (C) | 2014-12-11 | 2014-12-12 | RIALTO TRIAL | 02 | N | 210041385 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210027955 | 210013557 | 1.77 | 71.6 | Palliative (P) | 2018-05-01 | 2018-08-28 | R GCVP | Y | N | 210041403 | NELARABINE |
| 210027956 | 210013560 | 1.53 | 94.8 | Disease modification (D) | null | 2017-05-04 | RIALTO TRIAL | N | N | 210041408 | CARBOPLATIN + ETOPOSIDE |
| 210027957 | 210033673 | 1.68 | 80.8 | null | 2014-05-29 | 2014-06-04 | CARBOPLATIN + VINCRISTINE | null | Y | 210041423 | CARBOPLATIN + VINCRISTINE |
| 210027958 | 210022481 | null | 115 | Curative (C) | 2016-07-01 | 2016-07-05 | LOMUSTINE + PROCARBAZINE | 2 | N | 210041428 | LOMUSTINE + PROCARBAZINE |
| 210027959 | 210013565 | 0.85 | 15.4 | null | 2015-06-26 | 2016-01-09 | LOMUSTINE + PROCARBAZINE | N | N | 210041452 | LOMUSTINE + PROCARBAZINE |
| 210027960 | 210013566 | 0.87 | 65 | null | null | 2015-05-11 | Nelarabine | null | null | 210041459 | BENDAMUSTINE |
| 210027961 | 210013570 | 1.67 | 69 | Disease modification (D) | 2015-09-29 | 2015-09-29 | RIALTO TRIAL | N | N | 210041472 | ERWINIA ASPARAGINASE |
| 210027962 | 210013571 | 1.88 | 101 | Disease modification (D) | null | 2014-12-21 | PONATINIB | N | N | 210041488 | PONATINIB |
| 210027963 | 210022485 | null | null | Palliative (P) | 2013-09-03 | 2013-09-12 | Bendamustine + prednisolone | 2 | N | 210041488 | METHOTREXATE HIGH DOSE |
| 210027964 | 210013572 | 1.9 | 12.8 | Disease modification (D) | 2014-08-16 | 2015-03-02 | Nelarabine | N | N | 210041504 | BEVACIZUMAB |
| 210027965 | 210013573 | 1.88 | 89.9 | Adjuvant (A) | 2016-11-15 | 2017-02-15 | Procarbazine | N | null | 210041517 | PROCARBAZINE |
| 210027966 | 210013574 | 1.82 | null | Disease modification (D) | 2010-12-31 | 2013-04-10 | CARBOPLATIN + VINCRISTINE | N | N | 210041519 | CARBOPLATIN + VINCRISTINE |
| 210027967 | 210013576 | 0 | null | null | 2013-12-27 | 2014-04-05 | Methotrexate High Dose (3g/m2) | N | N | 210041526 | CARBOPLATIN + ETOPOSIDE |
| 210027968 | 210013578 | 1.83 | 68 | Curative (C) | 2018-09-17 | 2018-09-17 | Cyclophosphamide TBI Allograft | 02 | N | 210041546 | CYCLOPHOSPHAMIDE |
| 210027969 | 210022489 | 1.83 | 90 | Curative (C) | 2015-05-08 | 2015-05-18 | CLADRIBINE | 02 | N | 210041547 | CLADRIBINE |
| 210027970 | 210013583 | 1.64 | 77 | Disease modification (D) | 2018-04-03 | 2018-10-17 | Pentostatin | N | N | 210041556 | INOTUZUMAB OZOGAMICIN |
| 210027971 | 210022491 | 1.61 | null | Palliative (P) | 2018-06-19 | 2018-06-26 | Inotuzumab Ozogamicin | N | N | 210041569 | CARBOPLATIN + ETOPOSIDE |
| 210027972 | 210013587 | 1.23 | 66.5 | Disease modification (D) | 2014-04-18 | 2014-04-18 | IDELALISIB | N | N | 210041577 | BEVACIZUMAB |
| 210027973 | 210013588 | 1.78 | null | Adjuvant (A) | 2017-05-24 | 2017-05-24 | Methotrexate High Dose (3g/m2) | N | N | 210041579 | PENTOSTATIN |
| 210027974 | 210028103 | 0 | 30 | Palliative (P) | 2015-03-05 | 2015-03-05 | Procarbazine | N | N | 210041584 | PROCARBAZINE |
| 210027975 | 210038806 | null | null | Palliative (P) | null | 2015-03-14 | Methotrexate High Dose (3g/m2) | null | N | 210041599 | CVP R |
| 210027976 | 210038806 | 1.6 | 33.5 | Curative (C) | 2018-01-23 | 2018-01-30 | CHLORAMBUCIL + OFATUMUMAB | 02 | N | 210041599 | INOTUZUMAB OZOGAMICIN |
| 210027977 | 210037863 | null | 79.2 | Curative (C) | 2013-10-10 | 2013-10-28 | Cyclophosphamide Fludarabine (Oral) | N | N | 210041615 | CYCLOPHOSPHAMIDE + FLUDARABINE |